Quest Partners LLC Purchases 982 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Quest Partners LLC grew its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 98,200.0% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 983 shares of the biotechnology company’s stock after purchasing an additional 982 shares during the quarter. Quest Partners LLC’s holdings in Axon Enterprise were worth $289,000 as of its most recent SEC filing.

Other institutional investors have also recently modified their holdings of the company. ICA Group Wealth Management LLC bought a new position in shares of Axon Enterprise during the 4th quarter valued at about $26,000. Blue Trust Inc. boosted its holdings in Axon Enterprise by 987.5% during the 2nd quarter. Blue Trust Inc. now owns 87 shares of the biotechnology company’s stock valued at $27,000 after acquiring an additional 79 shares during the period. Trivant Custom Portfolio Group LLC purchased a new stake in Axon Enterprise during the 1st quarter valued at about $31,000. First PREMIER Bank purchased a new stake in Axon Enterprise during the 1st quarter valued at about $33,000. Finally, Blue Bell Private Wealth Management LLC purchased a new stake in Axon Enterprise during the 1st quarter valued at about $41,000. 79.08% of the stock is currently owned by institutional investors.

Axon Enterprise Stock Down 1.3 %

Axon Enterprise stock opened at $379.61 on Friday. The firm has a market cap of $28.69 billion, a price-to-earnings ratio of 111.00, a PEG ratio of 9.69 and a beta of 0.94. The stock has a fifty day simple moving average of $338.92 and a two-hundred day simple moving average of $314.65. Axon Enterprise, Inc. has a 12 month low of $189.12 and a 12 month high of $385.00. The company has a current ratio of 2.88, a quick ratio of 2.52 and a debt-to-equity ratio of 0.35.

Axon Enterprise (NASDAQ:AXON) last released its quarterly earnings results on Tuesday, August 6th. The biotechnology company reported $1.20 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.02 by $0.18. The firm had revenue of $504.00 million for the quarter, compared to the consensus estimate of $478.35 million. Axon Enterprise had a return on equity of 9.34% and a net margin of 16.06%. The company’s revenue for the quarter was up 34.5% on a year-over-year basis. During the same period last year, the business posted $0.80 EPS. Equities analysts predict that Axon Enterprise, Inc. will post 1.79 EPS for the current fiscal year.

Wall Street Analyst Weigh In

AXON has been the subject of several analyst reports. Jefferies Financial Group assumed coverage on Axon Enterprise in a report on Wednesday, July 17th. They set a “buy” rating and a $385.00 target price for the company. Bank of America assumed coverage on Axon Enterprise in a report on Wednesday, July 17th. They issued a “buy” rating and a $380.00 price objective for the company. Robert W. Baird increased their price objective on Axon Enterprise from $360.00 to $400.00 and gave the stock an “outperform” rating in a report on Tuesday, September 10th. Barclays raised their target price on Axon Enterprise from $381.00 to $387.00 and gave the company an “overweight” rating in a research note on Wednesday, August 7th. Finally, JMP Securities raised their target price on Axon Enterprise from $375.00 to $430.00 and gave the company an “outperform” rating in a research note on Thursday. Two analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. According to data from MarketBeat, Axon Enterprise presently has a consensus rating of “Moderate Buy” and an average target price of $365.38.

Insider Transactions at Axon Enterprise

In other news, CEO Patrick W. Smith sold 80,300 shares of Axon Enterprise stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $371.78, for a total transaction of $29,853,934.00. Following the transaction, the chief executive officer now directly owns 3,015,366 shares of the company’s stock, valued at approximately $1,121,052,771.48. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. In other Axon Enterprise news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the firm’s stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $373.03, for a total transaction of $167,863.50. Following the sale, the director now directly owns 7,379 shares of the company’s stock, valued at $2,752,588.37. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO Patrick W. Smith sold 80,300 shares of the firm’s stock in a transaction dated Friday, August 23rd. The shares were sold at an average price of $371.78, for a total value of $29,853,934.00. Following the sale, the chief executive officer now directly owns 3,015,366 shares in the company, valued at $1,121,052,771.48. The disclosure for this sale can be found here. Insiders have sold 316,981 shares of company stock worth $115,281,744 in the last quarter. Company insiders own 6.10% of the company’s stock.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.